Omeprazole Arrow

Omeprazole, the active ingredient in Omeprazole Arrow, is a proton pump inhibitor presented as a strength/form for oral use. It treats gastro‑intestinal gastro‑reflux disease (GERD) and ulcer conditions in adult patients. GNH USA supplies Omeprazole Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Arrow is a proton pump inhibitor used in the management of acid‑related gastrointestinal disorders. - Gastro‑esophageal reflux disease (GERD): reduces stomach acid production to relieve heartburn and prevent mucosal damage. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers by maintaining a higher gastric pH. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Adverse reactions to Omeprazole Arrow may range from mild to severe.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of stomach upset. - Abdominal pain: mild discomfort in the upper abdomen. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low serum magnesium levels that may cause muscle cramps or arrhythmias. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Stevens‑Johnson syndrome: rare skin reaction with blistering and mucosal involvement. - Liver enzyme elevation: increased ALT/AST indicating hepatic stress.

When prescribing Omeprazole Arrow, clinicians should consider several safety aspects. - Assess renal function: adjust use in patients with severe renal impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Review long‑term use: monitor for potential vitamin B12 deficiency with prolonged therapy. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Drug‑interaction review: check concomitant medications for possible PK/PD interactions. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole Arrow can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atorvastatin: increased plasma concentration, raising risk of myopathy. - Methotrexate: elevated levels may enhance toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent monitoring. - Digoxin: modest rise in serum levels, may need dose adjustment. - Phenytoin: decreased clearance, potentially leading to toxicity.